Center for Vein Restoration, Greenbelt, Md.
Gunnarsson Consulting, Jupiter, Fla.
J Vasc Surg Venous Lymphat Disord. 2021 Mar;9(2):383-392. doi: 10.1016/j.jvsv.2020.08.003. Epub 2020 Aug 11.
To measure patient preferences for attributes associated with thermal ablation and nonthermal, nontumescent varicose vein treatments.
Data were collected from an electronic patient preference survey taken by 70 adult participants (aged 20 years or older) at three Center for Vein Restoration clinics in New Jersey from July 19, 2019, through August 13, 2019. Survey participation was voluntary and anonymous (participation rate of 80.5% [70/87]). Patients were shown 10 consecutive screens that displayed three hypothetical treatment scenarios with different combinations of six attributes of interest and a none option. Choice-based conjoint analysis estimated the relative importance of different aspects of care, trade-offs between these aspects, and total satisfaction that respondents derived from different healthcare procedures. Market simulation analysis compared clusters of attributes mimicking thermal ablation and nonthermal, nontumescent treatments.
Of the six attributes studied, out-of-pocket (OOP) expenditures were the most important to patients (37.2%), followed by postoperative discomfort (17.1%), risk of adverse events (16.3%), time to return to normal activity (11.0%), number of injections (10.0%), and number of visits (8.4%). Patients were willing to pay the most to avoid postoperative discomfort ($68.9) and risk of adverse events ($65.8). The market simulation analysis found that, regardless of the level of OOP spending, 60% to 80% of respondents favored attribute combinations corresponding with nonthermal, nontumescent procedures over thermal ablation, and that less than 1% of participants would forgo either treatment under no cost sharing.
Patients are highly sensitive to OOP costs for minimally invasive varicose vein treatments. Market simulation analysis favored nonthermal, nontumescent procedures over thermal ablation.
测量患者对与热消融和非热、非肿胀性静脉曲张治疗相关属性的偏好。
数据来自 2019 年 7 月 19 日至 8 月 13 日新泽西州三个静脉修复中心的 70 名成年参与者(年龄在 20 岁或以上)进行的电子患者偏好调查。调查参与是自愿和匿名的(参与率为 80.5%[70/87])。患者观看了 10 个连续的屏幕,显示了三种具有不同组合的假设治疗方案,有 6 个感兴趣的属性和一个无选项。基于选择的联合分析估计了不同护理方面的相对重要性、这些方面之间的权衡以及受访者从不同医疗保健程序中获得的总满意度。市场模拟分析比较了模拟热消融和非热、非肿胀治疗的属性集群。
在所研究的六个属性中,自付费用(OOP)支出对患者最重要(37.2%),其次是术后不适(17.1%)、不良事件风险(16.3%)、恢复正常活动的时间(11.0%)、注射次数(10.0%)和就诊次数(8.4%)。患者愿意为避免术后不适($68.9)和不良事件风险($65.8)支付最多的费用。市场模拟分析发现,无论 OOP 支出水平如何,60%至 80%的受访者更喜欢与非热、非肿胀性程序相对应的属性组合,而不到 1%的参与者在无成本共担的情况下会放弃任何一种治疗。
患者对微创静脉曲张治疗的自付费用非常敏感。市场模拟分析偏向于非热、非肿胀性程序而不是热消融。